loader
Please Wait
Applying Filters...

List of All Manufacturers & Suppliers of Amphetamine Aspartate Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
$ API Ref.Price (USD/KG) : 2,479Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 13Granules India Limited

02 6ANI Pharmaceuticals Inc

03 7Accord healthcare

04 17Actavis Inc

05 13Ajanta Pharma Limited

06 7Alkem Laboratories

07 7Alvogen

08 13Aurolife Pharma LLC

09 13Barr Laboratories

10 6CorePharma, LLC

11 6ENDO OPERATIONS

12 13Elite Laboratories

13 7Epic Pharma. LLC.

14 6Impax Laboratories

15 13Lannett Company, Inc.

16 17Mallinckrodt Pharmaceuticals

17 7NORVIUM BIOSCIENCE

18 5Neolpharma

19 6Nesher Pharmaceuticals USA LLC

20 7Nuvo Pharmaceuticals

21 13RHODES PHARMACEUTICALS LP

22 4Sandoz B2B

23 17Sun Pharmaceutical Industries Limited

24 10Takeda Pharmaceutical

25 21Teva Pharmaceutical Industries

26 6USpharma

27 7Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : TABLET;ORAL

Dosage Strength : 1.25MG;1.25MG;1.25MG;1.25MG

Packaging :

Approval Date : 2021-12-28

Application Number : 215771

Regulatory Info : RX

Registration Country : USA

Granules India

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : TABLET;ORAL

Dosage Strength : 1.875MG;1.875MG;1.875MG;1.875MG

Packaging :

Approval Date : 2021-12-28

Application Number : 215771

Regulatory Info : RX

Registration Country : USA

Granules India

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : TABLET;ORAL

Dosage Strength : 2.5MG;2.5MG;2.5MG;2.5MG

Packaging :

Approval Date : 2021-12-28

Application Number : 215771

Regulatory Info : RX

Registration Country : USA

Granules India

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : TABLET;ORAL

Dosage Strength : 3.125MG;3.125MG;3.125MG;3.125MG

Packaging :

Approval Date : 2021-12-28

Application Number : 215771

Regulatory Info : RX

Registration Country : USA

Granules India

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : TABLET;ORAL

Dosage Strength : 3.75MG;3.75MG;3.75MG;3.75MG

Packaging :

Approval Date : 2021-12-28

Application Number : 215771

Regulatory Info : RX

Registration Country : USA

Granules India

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG;5MG;5MG;5MG

Packaging :

Approval Date : 2021-12-28

Application Number : 215771

Regulatory Info : RX

Registration Country : USA

Granules India

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : TABLET;ORAL

Dosage Strength : 7.5MG;7.5MG;7.5MG;7.5MG

Packaging :

Approval Date : 2021-12-28

Application Number : 215771

Regulatory Info : RX

Registration Country : USA

Granules India

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 1.25MG;1.25MG;1.25MG;1.25MG

Packaging :

Approval Date : 2023-01-23

Application Number : 217027

Regulatory Info : RX

Registration Country : USA

Granules India

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 2.5MG;2.5MG;2.5MG;2.5MG

Packaging :

Approval Date : 2023-01-23

Application Number : 217027

Regulatory Info : RX

Registration Country : USA

Granules India

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 3.75MG;3.75MG;3.75MG;3.75MG

Packaging :

Approval Date : 2023-01-23

Application Number : 217027

Regulatory Info : RX

Registration Country : USA

Granules India

11

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 5MG;5MG;5MG;5MG

Packaging :

Approval Date : 2023-01-23

Application Number : 217027

Regulatory Info : RX

Registration Country : USA

Granules India

12

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 6.25MG;6.25MG;6.25MG;6.25MG

Packaging :

Approval Date : 2023-01-23

Application Number : 217027

Regulatory Info : RX

Registration Country : USA

Granules India

13

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : RX

Registration Country : USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 7.5MG;7.5MG;7.5MG;7.5MG

Packaging :

Approval Date : 2023-01-23

Application Number : 217027

Regulatory Info : RX

Registration Country : USA

Granules India

14

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Dosage Form : TABLET;ORAL

Dosage Strength : 1.25MG;1.25MG;1.25MG;1.25MG

Packaging :

Approval Date : 2023-10-06

Application Number : 217787

Regulatory Info : RX

Registration Country : USA

blank

15

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : ADDERALL 10

Dosage Form : TABLET;ORAL

Dosage Strength : 2.5MG;2.5MG;2.5MG;2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1996-02-13

Application Number : 11522

Regulatory Info : DISCN

Registration Country : USA

blank

16

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : ADDERALL 20

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG;5MG;5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1996-02-13

Application Number : 11522

Regulatory Info : DISCN

Registration Country : USA

blank

17

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : ADDERALL 5

Dosage Form : TABLET;ORAL

Dosage Strength : 1.25MG;1.25MG;1.25MG;1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-05-12

Application Number : 11522

Regulatory Info : DISCN

Registration Country : USA

blank

18

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : ADDERALL 30

Dosage Form : TABLET;ORAL

Dosage Strength : 7.5MG;7.5MG;7.5MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-05-12

Application Number : 11522

Regulatory Info : DISCN

Registration Country : USA

blank

19

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : ADDERALL 7.5

Dosage Form : TABLET;ORAL

Dosage Strength : 1.875MG;1.875MG;1.875MG;1.875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2000-08-31

Application Number : 11522

Regulatory Info : DISCN

Registration Country : USA

blank

20

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Brand Name : ADDERALL 12.5

Dosage Form : TABLET;ORAL

Dosage Strength : 3.125MG;3.125MG;3.125MG;3.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2000-08-31

Application Number : 11522

Regulatory Info : DISCN

Registration Country : USA

blank